Acro Biomedical (ACBM) Short-term Investments (2018 - 2023)
Acro Biomedical (ACBM) posted Short-term Investments of $4230.0 for Q3 2023, little changed on a QoQ basis from $4230.0 in Q2 2023.
Powered by 
Analysis
Acro Biomedical (ACBM) Short-term Investments (2018 - 2023) Analysis & Trends
Acro Biomedical has reported Short-term Investments for 3 years, with the latest figure at $4230.0 in Q3 2023.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $4230.0 in Q3 2023; TTM through Sep 2023 was $4230.0, a N/A change from a year earlier, with the FY2019 full-year figure at $4992.0, changed N/A from the prior year.
- Short-term Investments was $4230.0 for Q3 2023 at Acro Biomedical, roughly flat from $4230.0 in the prior quarter.
- The five-year high for Short-term Investments was $4992.0 in Q1 2019, with the low at $4230.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 4,230.00 |
| Jun 30, 2023 | 4,230.00 |
| Mar 31, 2023 | 4,230.00 |
| Sep 30, 2019 | 4,992.00 |
| Jun 30, 2019 | 4,992.00 |
| Mar 31, 2019 | 4,992.00 |
| Dec 31, 2018 | 4,992.00 |